Frontiers in Pharmacology (Jun 2021)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

  • L. McEvoy,
  • D. F. Carr,
  • M. Pirmohamed

DOI
https://doi.org/10.3389/fphar.2021.684162
Journal volume & issue
Vol. 12

Abstract

Read online

Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of drugs which are widely used globally for the treatment of pain and inflammation, and in the case of aspirin, for secondary prevention of cardiovascular disease. Chronic non-steroidal anti-inflammatory drug use is associated with potentially serious upper gastrointestinal adverse drug reactions (ADRs) including peptic ulcer disease and gastrointestinal bleeding. A few clinical and genetic predisposing factors have been identified; however, genetic data are contradictory. Further research is needed to identify clinically relevant genetic and non-genetic markers predisposing to NSAID-induced peptic ulceration.

Keywords